Content area

|
|

Hepatitis E og graviditet

Kvinde med datter i Chennai, Indien.
Forfatter(e)
Ebba Elisabeth Mannheimer1, Lene Holm Harritshøj2 & Terese Lea Katzenstein1 1) Infektionsmedicinsk Klinik, Rigshospitalet 2) Klinisk Immunologisk Afdeling, Rigshospitalet Ugeskr Læger 2016;178:V05160356
Reference: 
Ugeskr Læger 2016;178:V05160356
Blad nummer: 
Sidetal: 
2-5
Hepatitis E and pregnancy
Hepatitis E virus (HEV) infection among pregnant women is severe, often leading to fulminant hepatic failure and death, with mortality rates up to 15-25%. Studies suggest that differences in genotypes/subgenotypes, hormonal and immunological changes during pregnancy may contribute to the severe consequences for pregnant women with HEV. Although the increased mortality among pregnant women predominantly is seen in developing countries where genotype 1 is endemic, there are also large differences in mortality among pregnant women within these countries. The reason for this is not clear.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anna Birthe Holmehøj Bach | 04/12
1 Kommentar
af Susanne L. M. Bülow | 03/12
1 Kommentar
af Andreas Gothardt Lundh | 02/12
1 Kommentar
af Michael Uldall Steinfath | 01/12
1 Kommentar
af Pedram Kazemi-Esfarjani | 01/12
1 Kommentar
af Bjarne Stigsby | 30/11
2 kommentarer
af Camilla Bang | 29/11
2 kommentarer
af Stine Madsen-Østerbye | 29/11
1 Kommentar